James Cassella
Director/Board Member chez TREVI THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
James V.
Cassella is an Independent Director at Trevi Therapeutics, Inc. and the Chief Development Officer & Senior Vice President at Concert Pharmaceuticals, Inc. He was previously the Senior VP-Clinical Research & Development at Neurogen Corp.
from 1989 to 2004 and the CSO, Executive VP-Research & Development at Alexza Pharmaceuticals, Inc. from 2013 to 2015.
He also worked as an Assistant Professor at Oberlin College.
Cassella holds a doctorate degree from Dartmouth College and an undergraduate degree from the University of New Haven.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TREVI THERAPEUTICS, INC.
-.--% | 28/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de James Cassella
| Sociétés | Poste | Début |
|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 04/02/2015 |
| TREVI THERAPEUTICS, INC. | Director/Board Member | 13/02/2020 |
Anciens postes connus de James Cassella
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXZA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 29/01/2015 |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Corporate Officer/Principal | 01/06/2004 |
| Oberlin College | Corporate Officer/Principal | - |
Formation de James Cassella
| Dartmouth College | Doctorate Degree |
| University of New Haven | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
